Facebook
Instagram
Twitter
Youtube
Sign in
Home
About Us
History
Editorial Board
Open Access and Copyright
Advertise With Us
Issues
Current Issue
Past Issues
Featured Articles
e-Journals
Online First
Instructions for Authors
Be a Reviewer
Submission & Review
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
Annals Singapore
Subscribe
Search
Advanced Search
Home
About Us
History
Editorial Board
Open Access and Copyright
Advertise With Us
Issues
Current Issue
Past Issues
Featured Articles
e-Journals
Online First
Instructions for Authors
Be a Reviewer
Submission & Review
Search
Advanced Search
Tag: nirmatrelvir-ritonavir
Letter to the Editor
COVID-19 residual symptoms and adverse drug reactions after oral antiviral therapy...
Diane Pulvera
-
26 December 2024
Letter to the Editor
Delayed treatment with nirmatrelvir/ritonavir could remain effective in patients with Omicron...
Annals Admin
-
30 March 2023
Review Article
Drug interactions between common dermatological medications and the oral anti-COVID-19 agents...
Annals Admin
-
27 December 2022
Editorial
Pharmacokinetic and pharmacogenomic considerations in managing use of nirmatrelvir-ritonavir and molnupiravir...
Annals Admin
-
27 December 2022
- Advertisement -
